XML 18 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities    
Net (loss) income $ (918,633) $ 1,867,324
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization 2,540,963 2,492,003
Interest from amortization of debt costs 112,618 13,704
(Gain) loss on disposal of property and equipment (92,868) 3,315
Stock-based compensation on stock options & RSU, net 296,297 279,397
Provision for doubtful accounts receivable (4,436) (11,868)
Change in fair value of warrant liability 0 194,632
Change in fair value of Sellers Note 0 (396,163)
Deferred rent amortization (52,720) (58,234)
Inventory write-offs to reserve 3,193 134,052
Deferred tax benefit (406,000) (205,884)
Changes in operating assets and liabilities:    
Trade accounts receivables (523,661) 312,026
Other receivables 42,575 (29,018)
Inventories (1,614,551) (1,013,201)
Prepaid expenses and other assets 181,200 (409,137)
Accounts payable and accrued liabilities 461,970 (500,237)
Net cash provided by operating activities 25,947 2,672,711
Cash flows from investing activities    
Purchase of property and equipment (1,673,482) (2,481,715)
Proceeds from sale of equipment 316,750 0
Net cash used in investing activities (1,356,732) (2,481,715)
Cash flows from financing activities    
Proceeds from exercise of stock options 13,767 194,150
Proceeds from sale of common stock from employee stock purchase plan 41,922 48,591
Loan costs (92,860) (60,453)
Borrowings on loan payable 5,813,500 2,942,583
Proceeds from exercise of warrants, net of costs 0 534,318
Payments on loan payable (6,686,167) (4,351,836)
Payments on capital lease obligations (244,210) (196,790)
Net cash used in financing activities (1,154,048) (889,437)
Effect of exchange rate on cash and cash equivalents 617,670 (998,410)
Change in cash and cash equivalents and restricted cash (1,867,163) (1,696,851)
Cash and cash equivalents and restricted cash, beginning of period 6,508,620 8,085,015
Cash and cash equivalents and restricted cash, end of period 4,641,457 6,388,164
Supplemental disclosure of cash flow information:    
Interest paid in cash 379,539 417,550
Income taxes paid 297,599 562,491
Supplemental disclosure of non-cash investing & financing activities:    
Purchase of equipment through capital lease arrangements 462,209 306,220
Reclassification of warrant liability upon exercise 0 685,132
Derecognition of liability associated with stock option grants 0 283,399
Conversion of sellers note to common stock $ 0 $ 2,247,064